Published on 25 November 2019
Latest features in GaBI Journal, 2019, Issue 3
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2019.0803.011
2.310 views
Published on 25 November 2019
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2019.0803.011
2.310 views
Published on 28 October 2019
Author(s): Maria Fabiana Jorge, MBA
access to medicines, biosimilars, generic drugs, trade agreements, USMCA
DOI: 10.5639/gabij.2020.0901.005
4.071 views
Published on 28 October 2019
Author(s): Zorana Maravic, BSc, MBA
biosimilars, colorectal cancer, digestive cancers, patients, position paper
DOI: 10.5639/gabij.2019.0803.017
3.981 views
Published on 02 October 2019
1.917 views
Published on 22 August 2019
2.218 views
Published on 21 August 2019
Author(s): Michael S Reilly, Esq, Professor Philip J Schneider, MS, FASHP, FASPEN, FFIP
biologicals/biosimilars, competition, patients, procurement, substitution, sustainability
DOI: 10.5639/gabij.2020.0902.013
17.147 views
Published on 14 August 2019
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2019.0802.006
3.512 views
Published on 29 May 2019
2.361 views
Published on 29 May 2019
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2019.0801.001
2.641 views
Published on 29 May 2019
Author(s): Alfredo García Arieta, PhD
DOI: 10.5639/gabij.2019.0801.005
15.037 views
Published on 21 May 2019
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2019.0801.004
8.650 views
Published on 28 January 2019
2.537 views